SEARCH RESULTS FOR: ("源头企业签名[Contact Telegram: duo785].hfs")(1292 results)
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0066
In Commercial Distribution
- 07540127000505 ()
- 07540127000499 ()
- 07540127000512 ()
- Area/Surface Area: 512 Square inch
CL1632
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0065
In Commercial Distribution
- 07540127000444 ()
- 07540127000437 ()
- 07540127000451 ()
- Area/Surface Area: 256 Square inch
CL1616
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0064
In Commercial Distribution
- 07540127000413 ()
- 07540127000406 ()
- 07540127000420 ()
- Area/Surface Area: 128 Square inch
CL0816
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0063
In Commercial Distribution
- 07540127000383 ()
- 07540127000376 ()
- 07540127000390 ()
- Area/Surface Area: 36 Square inch
CL0606
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0062
In Commercial Distribution
- 07540127000352 ()
- 07540127000345 ()
- 07540127000369 ()
- Area/Surface Area: 20 Square inch
CL0405
- Wound-nonadherent dressing, absorbent, antimicrobial
Surgaflex PainGuard, 4cm x 20cm
IMBED BIOSCIENCES, INC.
SFPG0420
In Commercial Distribution
- 00850019162356 ()
- Exudate-absorbent first aid dressing, hydrophilic-gel, antimicrobial
Surgaflex PainGuard, 4cm x 10cm
IMBED BIOSCIENCES, INC.
SFPG0410
In Commercial Distribution
- 00850019162349 ()
- Exudate-absorbent first aid dressing, hydrophilic-gel, antimicrobial
Surgaflex PainGuard, 4cm x 6cm
IMBED BIOSCIENCES, INC.
SFPG0406
In Commercial Distribution
- 00850019162332 ()
- Exudate-absorbent first aid dressing, hydrophilic-gel, antimicrobial
Surgaflex PainGuard, 2cm x 3cm
IMBED BIOSCIENCES, INC.
SFPG0203
In Commercial Distribution
- 00850019162325 ()
- Exudate-absorbent first aid dressing, hydrophilic-gel, antimicrobial
Surgaflex, 4cm x 20cm, Individually packaged
IMBED BIOSCIENCES, INC.
91018
In Commercial Distribution
- 00850019162318 ()
- Exudate-absorbent first aid dressing, hydrophilic-gel, antimicrobial